These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12131145)

  • 1. FDA "black box" warning regarding use of droperidol for postoperative nausea and vomiting: is it justified?
    Gan TJ; White PF; Scuderi PE; Watcha MF; Kovac A
    Anesthesiology; 2002 Jul; 97(1):287. PubMed ID: 12131145
    [No Abstract]   [Full Text] [Related]  

  • 2. Pro: The Food and Drug Administration Black box warning on droperidol is not justified.
    Habib AS; Gan TJ
    Anesth Analg; 2008 May; 106(5):1414-7. PubMed ID: 18420854
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA response to droperidol black box warning editorials.
    Rappaport BA
    Anesth Analg; 2008 May; 106(5):1585. PubMed ID: 18420886
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of droperidol before and after the Food and Drug Administration black box warning: a survey of the members of the Society of Ambulatory Anesthesia.
    Habib AS; Gan TJ
    J Clin Anesth; 2008 Feb; 20(1):35-9. PubMed ID: 18346607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The FDA droperidol warning: is it justified?
    Bailey P; Norton R; Karan S
    Anesthesiology; 2002 Jul; 97(1):288-9. PubMed ID: 12131147
    [No Abstract]   [Full Text] [Related]  

  • 6. Droperidol: should the black box be light gray?
    Dershwitz M
    J Clin Anesth; 2002 Dec; 14(8):598-603. PubMed ID: 12565120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Con: The black box warning on droperidol should not be removed (but should be clarified!).
    Ludwin DB; Shafer SL
    Anesth Analg; 2008 May; 106(5):1418-20. PubMed ID: 18420855
    [No Abstract]   [Full Text] [Related]  

  • 8. Does low-dose droperidol administration increase the risk of drug-induced QT prolongation and torsade de pointes in the general surgical population?
    Nuttall GA; Eckerman KM; Jacob KA; Pawlaski EM; Wigersma SK; Marienau ME; Oliver WC; Narr BJ; Ackerman MJ
    Anesthesiology; 2007 Oct; 107(4):531-6. PubMed ID: 17893447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Droperidol editorial: making a mountain out of a mole hill!
    Bailey P; White PF
    Anesthesiology; 2003 Sep; 99(3):760-1; author reply 761. PubMed ID: 12960572
    [No Abstract]   [Full Text] [Related]  

  • 10. Inside the black box: current policies and concerns with the United States Food and Drug Administration's highest drug safety warning system.
    Halloran K; Barash PG
    Curr Opin Anaesthesiol; 2010 Jun; 23(3):423-7. PubMed ID: 20446348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Droperidol: many questions, few answers.
    Scuderi PE
    Anesthesiology; 2003 Feb; 98(2):289-90. PubMed ID: 12552182
    [No Abstract]   [Full Text] [Related]  

  • 12. Low-dose droperidol.
    Allen G
    CMAJ; 2002 Sep; 167(5):452; author reply 452. PubMed ID: 12240805
    [No Abstract]   [Full Text] [Related]  

  • 13. Unexpected cardiovascular deaths are rare with therapeutic doses of droperidol.
    Mullins M; Van Zwieten K; Blunt JR
    Am J Emerg Med; 2004 Jan; 22(1):27-8. PubMed ID: 14724874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Droperidol "box warning" warrants scrutiny.
    Ben-David B; Weber S; Chernus S
    Anesthesiology; 2002 Jul; 97(1):288. PubMed ID: 12131146
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug-induced prolongation of the QT interval: what's the point?
    White PF; Abrao J
    Anesthesiology; 2006 Feb; 104(2):386-7. PubMed ID: 16436877
    [No Abstract]   [Full Text] [Related]  

  • 16. Haloperidol: an alternative butyrophenone for nausea and vomiting prophylaxis in anesthesia.
    Smith JC; Wright EL
    AANA J; 2005 Aug; 73(4):273-5. PubMed ID: 16108408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Droperidol--behind the black box warning.
    Horowitz BZ; Bizovi K; Moreno R
    Acad Emerg Med; 2002 Jun; 9(6):615-8. PubMed ID: 12045077
    [No Abstract]   [Full Text] [Related]  

  • 18. Haloperidol for postoperative nausea and vomiting: are we reinventing the wheel?
    Habib AS; Gan TJ
    Anesth Analg; 2008 May; 106(5):1343-5. PubMed ID: 18420842
    [No Abstract]   [Full Text] [Related]  

  • 19. An overview of intravenous amisulpride as a new therapeutic option for the prophylaxis and treatment of postoperative nausea and vomiting.
    Smyla N; Koch T; Eberhart LH; Gehling M
    Expert Opin Pharmacother; 2020 Apr; 21(5):517-522. PubMed ID: 31971450
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of droperidol and ondansetron on dispersion of myocardial repolarization in children.
    Mehta D; Sanatani S; Whyte SD
    Paediatr Anaesth; 2010 Oct; 20(10):905-12. PubMed ID: 20849495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.